Dixon's report 30 Oct - re cure for "patent's" with back problems - Kt009. Why wasn't this reported in Bishop's annual report only 4 days earlier - lack of communication or some other reason ?
Re Dixon's exciting new product announcement - the combination of two, old unproven products/ideas has failure written all over it - syringe patent 2006 - Kt009 patent 2007 (syringe only a drawing with a number) - not much of a choice out of the seventy odd products they assessed. I can't see this happening in my lifetime.
- Forums
- ASX - By Stock
- Ann: Technology License and Clinial Development Program Agreement
Dixon's report 30 Oct - re cure for "patent's" with back...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity